SPI Infoamtion

このレポートは章ごとの個別販売も行っておりますのでお問い合わせ下さい。
※全てPDFでの販売となります。

Chapter- 1: INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
DEFINING POC
METHODOLOGY
ANALYST CREDENTIALS
RELATED REPORTS
BCC ON-LINE SERVICES
DISCLAIMER

Chapter- 2: SUMMARY
OVERVIEW
MAJOR FINDINGS
Table 0 : FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, THROUGH 2016
Figure 0 : FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, 2009-2016

Chapter- 3: INDUSTRY OVERVIEW
WHAT IS POC TESTING?
OVERVIEW OF POC MARKET
POC AS PART OF CLINICAL DIAGNOSTICS INDUSTRY STRUCTURE
POC TESTING SITES
POC PRODUCT SEGMENTS
COMMONLY PERFORMED POC TESTS
SIGNIFICANCE OF CLIA IN THE UNITED STATES
OTHER REGULATORY AGENCIES
INITIATIVE FOR HIV/AIDS TESTING
DRIVING FORCES OF THE POC MARKET
NEW ATTENTION TO DRUGS OF ABUSE

Chapter- 4: THE POC MARKET
MARKET OVERVIEW
COMPETITOR MARKET SHARE
MARKET STRUCTURE
MARKET COMPONENTS

Chapter- 5: TECHNOLOGY APPLICATIONS
BIOSENSORS
ELECTRODES
CONTINUOUS TESTING
RAPID HIV TESTS
DRUG TESTING
PATENT ANALYSIS

Chapter- 6: WORLDWIDE POC MARKET
MARKET SIZE
GLOBAL MARKET SHARES
PRESENCE OF MANUFACTURERS IN THE WORLDWIDE MARKET
Table 64 : MARKET SHARE OF MAJOR POC MARKET PARTICIPANTS, 2011
Figure 40 : MARKET SHARE MAJOR POC MARKET PARTICIPANTS, 2011

Chapter- 7: PROFILES OF MAJOR MARKET PARTICIPANTS
OVERVIEW OF MARKET PARTICIPANTS
COMPANY PROFILES

Chapter- 8: APPENDIX
KEY SOURCES OF INFORMATION

List of Tables
Summary Table : FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, THROUGH 2016
Table 1 : SELECTED KEY STATISTICS FOR POC TESTING SITES
Table 2 : NUMBER OF HOSPITALS FOR SELECTED COUNTRIES, 2009
Table 3 : NUMBER OF U.S. HEALTHCARE FACILITIES BY TYPE, 2009*
Table 4 : SELECTED POC TESTS – CLIA WAIVED
Table 5 : PERTINENT PARAMETERS OF GMP REGULATIONS AFFECTING IN VITRO DIAGNOSTICS
Table 6 : HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY COUNTRY: 1980-2008
Table 7 : HOSPITAL USAGE STATISTICS, AVERAGE, 2000-2010
Table 8 : WORLD HEALTH ORGANIZATION RANKING OF HEALTHCARE SYSTEMS, TOP 50, 2000
Table 9 : STATISTICS OF SELECTED DISEASES IN THE GLOBAL POPULATION, 2009-2010 ESTIMATES
Table 10 : BIRTH RATES AND BIRTHS BY COUNTRY, 2010 ESTIMATES
Table 11 : GLOBAL POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND SELECTED YEARS, THROUGH 2030
Table 12 : GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015
Table 13 : GLOBAL FORECAST FOR THE POC MARKET, THROUGH 2016
Table 14 : MARKET SHARE OF MAJOR POC MARKET PARTICIPANTS, 2011
Table 15 : FORECAST OF THE GLOBAL POC BLOOD GAS/ELECTROLYTE TESTING MARKET, THROUGH 2016
Table 16 : RELATIVE MARKET SHARE OF POC BLOOD CHEMISTRY ANALYZER MANUFACTURERS, 2011
Table 17 : NOVA BIOCHEMICAL POC STAT PROFILE PHOX SERIES BY AVAILABLE TESTS
Table 18 : NOVA BIOCHEMICAL POC STAT PROFILE CCX SERIES BY AVAILABLE TESTS
Table 19 : FORECAST OF THE GLOBAL POC CARDIAC MARKER TESTING MARKET, THROUGH 2016
Table 20 : RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS, 2011
Table 21 : FORECAST OF THE GLOBAL CHOLESTEROL POC RAPID TEST MARKET, THROUGH 2016
Table 22 : RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS, 2011
Table 23 : RECENT (2010-2011) CLIA-WAIVED APPROVED CHOLESTEROL TESTS
Table 24 : FORECAST OF THE GLOBAL DRUG AND ALCOHOL POC RAPID TEST MARKET, THROUGH 2016
Table 25 : RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST MANUFACTURERS, 2011
Table 26 : RECENT (2010-2011) CLIA-WAIVED APPROVED POC DRUG AND ALCOHOL SCREENING TESTS
Table 27 : FORECAST OF THE GLOBAL POC GLUCOSE METER MARKET, THROUGH 2016
Table 28 : MARKET SHARE FOR THE GLOBAL POC GLUCOSE METER MARKET BY COMPONENT, 2011
Table 29 : RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES MANUFACTURERS, 2011
Table 30 : RECENT (2010-2011) CLIA-WAIVED APPROVED BLOOD GLUCOSE METERS
Table 31 : SELECTED LISTING OF RETAILERS SELLING HOME DIAGNOSTIC’S METERS
Table 32 : SELECT LISTING OF BLOOD GLUCOSE MONITORS CAPABLE OF INTERACTING WITH COMPUTER SOFTWARE
Table 33 : RECENT (2010-2011) CLIA-WAIVED APPROVED STREP A TESTS
Table 34 : RECENT (2010-2011) CLIA-WAIVED APPROVED INFLUENZA TESTS
Table 35 : RECENT (2010–2011) CLIA-WAIVED APPROVED RSV TESTS
Table 36 : RECENT (2010-2011) CLIA-WAIVED APPROVED HIV TESTS
Table 37 : RECENT (2010-2011) CLIA-WAIVED APPROVED INFECTIOUS MONONUCLEOSIS TESTS
Table 38 : RECENT (2010–2011) CLIA-WAIVED APPROVED H. PYLORI TESTS
Table 39 : FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET, THROUGH 2016
Table 40 : MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY TEST TYPE, 2011
Table 41 : RELATIVE MARKET SHARE OF INFECTIOUS DISEASE POC RAPID TEST MANUFACTURERS, 2011
Table 42 : FORECAST OF THE GLOBAL PREGNANCY/FERTILITY POC RAPID TEST MARKET, THROUGH 2016
Table 43 : MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY TEST TYPE, 2011
Table 44 : RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST MANUFACTURERS, 2011
Table 45 : RECENT (2010-2011) CLIA-WAIVED APPROVED PREGNANCY TESTS
Table 46 : FORECAST OF THE GLOBAL HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MARKET, THROUGH 2016
Table 47 : RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MANUFACTURERS, 2011
Table 48 : RECENT (2010-2011) CLIA-WAIVED APPROVED HEMATOLOGY TESTS
Table 49 : FORECAST OF THE GLOBAL TUMOR MARKER POC RAPID TEST MARKET, THROUGH 2016
Table 50 : RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST MANUFACTURERS, 2011
Table 51 : RECENT (2010-2011) CLIA-WAIVED APPROVED FECAL OCCULT BLOOD TESTS
Table 52 : RECENT (2010-2011) CLIA-WAIVED APPROVED BLADDER TESTS
Table 53 : FORECAST OF THE GLOBAL POC URINE CHEMISTRY ANALYZER MARKET, THROUGH 2016
Table 54 : RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER MANUFACTURERS, 2011
Table 55 : RECENT (2010-2011) CLIA-WAIVED APPROVED URINE CHEMISTRY ANALYZERS
Table 56 : RECENT (2010-2011) CLIA-WAIVED APPROVED VAGINAL PH TESTS
Table 57 : RECENT (2010-2011) CLIA-WAIVED APPROVED TSH TESTS
Table 58 : RECENT (2010-2011) CLIA-WAIVED APPROVED MALE REPRODUCTIVE TESTS
Table 59 : RESULTS OF U.S. PATENT SEARCH FOR POC CATEGORIES, JANUARY 2009 TO NOVEMBER 2011
Table 60 : U.S. PATENTS BY SUBJECT AREA, JANUARY 2009 TO NOVEMBER 2011
Table 61 : PATENT ASSIGNEES BY COUNTRY, JANUARY 2009 TO NOVEMBER 2011
Table 62 : GLOBAL FORECAST FOR THE POC MARKET, THROUGH 2016
Table 63 : POC GLOBAL MARKET SHARE BY REGION, 2011
Table 64 : MARKET SHARE OF MAJOR POC MARKET PARTICIPANTS, 2011
Table 65 : ABAXIS’ COMPANY REVENUES, 2006-2010*
Table 66 : ABBOTT’S COMPANY REVENUES, 2006-2010
Table 67 : ALERE’S COMPANY REVENUES, 2006-2010
Table 68 : BECKMAN COULTER’S COMPANY REVENUES, 2006-2010
Table 69 : BECTON DICKINSON’S COMPANY REVENUES, 2006-2011*
Table 70 : CHURCH & DWIGHT’S COMPANY REVENUES, 2006-2010
Table 71 : DANAHER’S COMPANY REVENUES, 2006-2010
Table 72 : QUEST’S COMPANY REVENUES, 2006-2010
Table 73 : ITC’S COMPANY SALES, 2008-2010
Table 74 : JOHNSON & JOHNSON’S COMPANY REVENUES, 2006-2010
Table 75 : NIPRO CORPORATION’S COMPANY REVENUES, 2006-2010*
Table 76 : ORASURE’S COMPANY REVENUES, 2006-2010
Table 77 : QUIDEL’S COMPANY REVENUES, 2006-2010
Table 78 : ROCHE GROUP’S REVENUES, 2006-2010
Table 79 : SEKISUI CHEMICAL CO’S REVENUES, 2006-2010
Table 80 : SIEMENS’ COMPANY REVENUES, 2006-2010
Table 81 : SPECTRAL’S COMPANY REVENUES, 2007-2010
Table 82 : TRINITY’S COMPANY REVENUES, 2006-2010

List of Figures
Summary Figure : FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, 2009-2016
Figure 1 : HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY, 1980-2008
Figure 2 : HOSPITAL USAGE STATISTICS
Figure 3 : BIRTH RATES AND BIRTHS BY COUNTRY, 2010 ESTIMATES
Figure 4 : GLOBAL POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000–2030
Figure 5 : GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND PROJECTED 2015
Figure 6 : GLOBAL FORECAST FOR THE POC MARKET, 2009-2016
Figure 7 : DISTRIBUTION OF SALES FOR THE GLOBAL POC MARKET BY TEST TYPE, 2011
Figure 8 : MARKET SHARE MAJOR POC MARKET PARTICIPANTS, 2011
Figure 9 : DISTRIBUTION CHANNELS: POC DIAGNOSTIC DEVICES
Figure 10 : FORECAST OF THE GLOBAL POC BLOOD GAS/ELECTROLYTE TESTING MARKET, 2009-2016
Figure 11 : RELATIVE MARKET SHARE BLOOD GAS ANALYZER MANUFACTURERS, 2011
Figure 12 : FORECAST OF THE GLOBAL POC CARDIAC MARKER TESTING MARKET, 2009-2016
Figure 13 : RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS, 2011
Figure 14 : FORECAST OF THE GLOBAL CHOLESTEROL POC RAPID TEST MARKET, 2009-2016
Figure 15 : RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST MANUFACTURERS, 2011
Figure 16 : FORECAST OF THE GLOBAL DRUG AND ALCOHOL POC RAPID TEST MARKET, THROUGH 2016
Figure 17 : RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST MANUFACTURERS, 2011
Figure 18 : FORECAST OF THE GLOBAL POC GLUCOSE METER MARKET, 2009-2016
Figure 19 : MARKET SHARE FOR THE GLOBAL POC GLUCOSE METER MARKET BY COMPONENT, 2011
Figure 20 : RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES MANUFACTURERS, 2011
Figure 21 : FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET, THROUGH 2016
Figure 22 : MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY TEST TYPE, 2011
Figure 23 : RELATIVE MARKET SHARE OF INFECTIOUS DISEASE POC RAPID TEST MANUFACTURERS, 2011
Figure 24 : FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET, 2008-2016
Figure 25 : MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY TEST TYPE, 2011
Figure 26 : RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST MANUFACTURERS, 2011
Figure 27 : FORECAST OF THE GLOBAL HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MARKET, THROUGH 2016
Figure 28 : RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST MANUFACTURERS, 2011
Figure 29 : FORECAST OF THE GLOBAL TUMOR MARKER POC RAPID TEST MARKET, THROUGH 2016
Figure 30 : RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST MANUFACTURERS, 2011
Figure 31 : FORECAST OF THE GLOBAL POC URINE CHEMISTRY ANALYZER MARKET, 2009-2016
Figure 32 : RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER MANUFACTURERS, 2011
Figure 33 : U.S. PATENTS BY POC CATEGORIES, JANUARY 2009 TO NOVEMBER 2011
Figure 34 : U.S. PATENTS BY SUBJECT AREA, JANUARY 2009 TO NOVEMBER 2011
Figure 35 : GLOBAL FORECAST FOR THE POC MARKET, THROUGH 2016
Figure 36 : POC GLOBAL MARKET SHARE BY REGION, 2011
Figure 37 : NORTH AMERICAN POC MARKET SHARE BY COUNTRY, 2011
Figure 38 : EUROPEAN POC MARKET SHARE BY COUNTRY, 2011
Figure 39 : ASIAN POC MARKET SHARE BY COUNTRY, 2011
Figure 40 : MARKET SHARE MAJOR POC MARKET PARTICIPANTS, 2011
Figure 41 : ABAXIS’ COMPANY REVENUES, 2006-2010*
Figure 42 : ABBOTTS’ COMPANY REVENUES, 2006-2010
Figure 43 : ALERE’S COMPANY REVENUES 2006–2010
Figure 44 : BECKMAN COULTER’S COMPANY REVENUES, 2006-2010
Figure 45 : BECTON DICKINSON’S COMPANY REVENUES, 2006-2011*
Figure 46 : CHURCH & DWIGHT’S COMPANY REVENUES, 2006-2010
Figure 47 : DANAHER’S COMPANY REVENUES, 2006–2010
Figure 48 : QUEST’S COMPANY REVENUES, 2006-2010
Figure 49 : ITC’S COMPANY SALES, 2008-2010
Figure 50 : JOHNSON & JOHNSON’S COMPANY REVENUES, 2006-2010
Figure 51 : NIPRO CORPORATION’S COMPANY REVENUES, 2006-2010*
Figure 52 : ORASURE’S COMPANY REVENUES, 2006-2010
Figure 53 : QUIDEL’S COMPANY REVENUES, 2006-2010
Figure 54 : ROCHE GROUP’S REVENUES, 2006-2010
Figure 55 : SEKISUI CHEMICAL CO’S REVENUES, 2006-2010
Figure 56 : SIEMENS’ COMPANY REVENUES, 2006-2010
Figure 57 : SPECTRAL’S COMPANY REVENUES, 2007-2010
Figure 58 : TRINITY’S COMPANY REVENUES, 2006-2010